cigna glp-1 program Cigna's Evernorth unveils 2 new programs aimed at GLP-1s Cigna prior authorization for Ozempic,

Research continues to examine how treatment duration and medication dose affect eye complication rates

Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (C(10))

This carefully calibrated receptor selectivity profile contributes to the favorable side effect profile observed in clinical studies, where gastrointestinal adverse events were predominantly mild and occurred mainly during dose escalation phases

healthcare landscape evolves, manufacturers who integrate PDTs into their market access strategy stand to gain a competitive advantage by aligning with evidence-driven, outcomes-based care models

But much more research is needed to truly understand how effective these practices are and at what dosage

Additionally, physicians can adjust medication type, dosing, or supportive interventions if initial approach isn't producing desired results